The endothelial microenvironment is critical in maintaining the health and function of the intimal layer in vasculature. In the context of cardiovascular disease (CVD), the vascular endothelium is the layer of initiation for the progression of atherosclerosis. While laminar blood flows are known to maintain endothelial homeostasis, disturbed flow conditions including those the endothelium experiences in the carotid artery are responsible for determining the fate of CVD progression. We present a microfluidic device designed to monitor the endothelium on two fronts: the real-time monitoring of the endothelial permeability using integrated electrodes and the end-point characterization of the endothelium through immunostaining. Our key findings demonstrate endothelial monolayer permeability and adhesion protein expression change in response to oscillatory shear stress frequency. These changes were found to be significant at certain frequencies, suggesting that a frequency threshold is needed to elicit an endothelial response. Our device made possible the real-time monitoring of changes in the endothelial monolayer and its end-point inspection through a design previously absent from the literature. This system may serve as a reliable research platform to investigate the mechanisms of various inflammatory complications of endothelial disorders and screen their possible therapeutics in a mechanistic and high-throughput manner.
The vascular endothelium is a vessel-lining barrier that controls the transport of biologically active molecules and regulates inflammation, blood pressure and clotting, and immune cell trafficking. Endothelial homeostasis is critical for maintaining cardiovascular health against the onset of diseases that manifest from cardiovascular disease (CVD)1. Atherosclerosis is one such disease that stems from the chronic inflammation of the endothelium2. Studies examining the mechanotransduction of endothelial cells have linked endothelial inflammatory responses, including adhesion protein expression and nitric oxide production, to shear stress magnitude and direction3,4,5. Certain areas in the body, like the carotid sinus that has a unique expanding vasculature geometry, have localized disturbed flow acting back and forth against the vascular wall with shear stresses from <10–12 dyne/cm2 (1–1.2 Pa) in humans (Fig. 1a)6, 7. While endothelial homeostasis is maintained in laminar shear stress (LSS) conditions, the prolonged exposure of the endothelium to oscillatory shear stress (OSS) caused by disturbed flow leads to the chronic inflammatory response, adversely increasing the risk of atherosclerosis and CVD initiation8,9,10.
Despite the understanding of the role of OSS-induced endothelial inflammation in several fatal diseases, challenges remain in sensing the inflamed endothelium under pathological blood flow (i.e. disturbed flow) and delivering sufficient therapeutic agents.
The implementation of atherosclerotic animal models has aided in the study of the disease progression and development of potential therapy options for the disease11. One such method to study the atherosclerotic pathology is to use the partial ligation surgery of the left carotid artery (LCA) in apoE−/− mice to apply disturbed flow and the resulting OSS to the endothelium and accelerate atherosclerotic plaque growth12. While these findings have improved our understanding of OSS-derived pathology in CVD, further progress in this area is hampered by technical challenges of conducting mechanistic studies on targeted drug discovery and development in the human vasculature. Moreover, extrapolation of animal data to human conditions has been frustratingly controversial, particularly for complex diseases afflicting dynamic microenvironments prevalent with mechanochemical stimuli such as blood flow and inflammatory cytokines13. Overcoming traditional in vitro models that predominantly rely on static culture of vascular endothelial cells, current advanced in vitro studies on endothelial mechanotransduction have taken the magnitude and direction of OSS into consideration to complement existing animal model research3, 4, 8, 9, 14,15,16. The frequencies typically associated to be characteristic of disease-causing OSS are based on measured physiological values in vivo; this value is about 5 Hz in mice, whereas in humans this level drops to approximately 1 Hz3, 10, 17. Despite sophisticated approaches to apply OSS in vitro, variations in endothelial cell responses to slight changes in the disturbed flow pattern may not be adequately reflected for studying certain mechanisms such as the dynamic interaction of the vascular endothelium with drugs in vivo 18, 19. More importantly, little work has questioned whether the endothelial response is affected by the frequency of OSS, which may be key to influence expression of pro-inflammatory proteins like VCAM-1, ICAM-1, or IL-820, 21. Consequently, emerging technologies like biomimetic microfluidic platforms are being developed to address questions like these by implementing physiological and pathological conditions in a minimalist in vitro setting of OSS-induced vascular complications.
Microfluidic platforms, some of which are called organ-on-a-chip systems, provide an unprecedented ability to control the mechanical and chemical microenvironment in a spatial and temporal fashion, enabling the studies of dynamic cellular responses to a variety of mechanical and chemical stimuli22. The capabilities to measure cellular responses from dynamic environments typically found in physiological systems, as well as the potential for high-throughput applications, make microfluidic technology a suitable medium through which to study shear-dependent endothelial responses with spatiotemporal manners and high precision. Microfluidic platforms have also grown to include screening tools to accelerate the development of therapeutics in physiological disease settings23. We report on the dependency of the endothelial inflammatory response to changes in OSS frequencies as presented through the implementation of a microfluidic transcellular monitor to dynamically examine the permeability and adhesion molecule expression level of an endothelial monolayer. Additionally, we report and address the challenges of widely used existing double-layered endothelialized microfluidic platforms; the endothelium near the channel wall fails to replicate physiologically relevant endothelial morphology and function in response to the application of shear, compromising the accuracy to investigate both the effect of mechanical and chemical cues on the endothelium and the translocation of nanoparticles across the endothelial barrier24. By imposing the accurate shear stress on primary human aortic endothelial cells (HAECs), as well as monitoring the endothelial permeability, our microfluidic transcellular monitor may provide a simple yet reliable platform to: (i) examine the underlying mechanisms by which vascular endothelial disorders occur and lead to complicated inflammatory pathologies, and (ii) efficiently test the efficacy of potential drug candidates targeting the dysfunctional endothelium in various mechanically (shear stress) and chemically (pro-inflammatory cytokines) stimulated pathophysiologically relevant conditions.
Microfluidic transcellular monitor design
The microfluidic transcellular monitor platform was designed to study the endothelial responses through electrical measurements and microscopy data that track the intercellular permeability and overall visual health of the monolayer in a multi-layer design (Fig. 1b). High-throughput and real-time monitoring of the endothelium was accomplished through an array of devices implementing the transendothelial electrical resistance (TEER) across the upper and lower microchannels using Ag/AgCl electrodes integrated into the device (Fig. 1c and Supplementary Fig. S1). This double-layered microfluidic platform uses a high endothelial cell seeding density to allow for the uniform coverage of endothelial cells across the microchannel. To address the issue of the non-homogenous morphological and functional responses of endothelial cells due to their proximity to the sharp corner of the microchannel wall and better model the vascular endothelium, we performed computational fluid dynamics (CFD) analyses to find that the endothelial monolayer would only experience the greatest directional changes in response to flow within the middle 50% of the upper microchannel width (Fig. 1d). We validated these CFD simulation results using human umbilical vein endothelial cells (HUVECs), a widely used endothelial cell type in vitro, cultured in the upper microchannel geometry on a glass substrate to show nearly a 30% decrease in mean cell area for cells growing in the middle of the microchannel under flow, the absence of which resulted in an insignificant difference in the mean cell area between the cells growing in the two regions (Supplementary Fig. 2). Taking into account both the TEER dependency on the overlapping area of the upper and lower microchannels and the CFD simulation results, the upper microchannel was designed to have twice the width of the lower microchannel (200 µm and 100 µm, respectively) so that we could monitor an area that would only include the middle 50% region of the upper microchannel (Fig. 1e). With this microchannel configuration, we were able to efficiently inspect the HAEC monolayer growth and maturation using TEER, the leveling-off of which identified the monolayer maturity with high reproducibility (Fig. 1f). Visual inspection of the HAEC monolayer through confocal microscopy was used in conjunction with TEER to gain a more representative understanding over how the endothelial monolayer responded to our flow-based stimuli (Fig. 1g).
Tailored platform more suitable for endothelial response monitoring
Using this new design that can accurately impose both the specific quantity and direction of shear stress on the endothelium cultured in the middle microchannel, we then investigated whether our microfluidic transcellular monitor was capable of accurately reconstituting pathophysiological conditions caused by shear stress profiles. We first cultured HAECs to form a monolayer to be exposed to LSS of +10 dyne/cm2 in order to investigate whether or not there is a locally distinct expression of EC proteins like the adhesion protein ICAM and the adherens junction protein β-catenin in the center region (defined as the middle 50% region) of the upper microchannel (Fig. 2a). Comparing the center region to the remaining area of the upper microchannel (defined as the edge region) yielded a non-significant difference in the β-catenin (Fig. 2b) and ICAM intensity (Fig. 2c). We then examined this effect with an HAEC monolayer exposed to OSS of +10 and −9 dyne/cm2 at 1 Hz (Fig. 2d). The comparison of the center region to the edge region yielded a non-significant difference in β-catenin intensity (Fig. 2e). However, there was nearly double the ICAM intensity expressed in the center region compared to that in the edge region (Fig. 2f). Following the verification of our simulation results with the observation of ICAM localization to the center region of the microchannel, the confocal imaging area for comparisons across devices with varying shear stress conditions was then defined to only include the center region due to the verified non-negligible effects of the microchannel wall. In following the same design intent, the choice to make the lower microchannel half as wide as the upper microchannel was to minimize the effect of the wall on TEER measurements. This is especially important for the accurate monitoring of the endothelial permeability in response to varying shear stress conditions, such as shear oscillation frequency, due to the direct influence the overlapping area of the upper and lower microchannels has on TEER measurements25.
Endothelial response is dependent on the OSS frequency
The carotid artery is a region of interest in CVD research due to its unique geometry to produce locally recirculating or disturbed flows. The shear stresses in these regions average to about 10 dyne/cm2, which is a commonly used shear stress value with HAECs under laminar flow in vitro 6, 7, 26, 27. Shear stresses of +10 and +10/−9 dyne/cm2 were used for the LSS and OSS conditions respectively to minimize variations in the flow conditions to be in OSS frequency while still allowing the refreshment of media in the devices. The net shear stress magnitude to be used between the OSS and LSS cases, +1 and +10 dyne/cm2 respectively, were compared through CFD-calculated WSS distributions, β-catenin intensity measurements, and ICAM intensity measurements in the center channel region (Fig. 3a and b). The HAEC monolayers matured in 24 hours under LSS of +10 dyne/cm2 (Fig. 1f), after which the various shear conditions were imposed for 12 hours (Supplementary Fig. S3). Between the +1 and +10 dyne/cm2 cases under LSS, the differences in TEER, β-catenin intensities, and ICAM intensities were insignificant (Fig. 3c–e). For the examination of the OSS frequency effects, the HAEC monolayers were cultured under 0X (LSS), 0.1X (OSS), and 1X (OSS) of the 1 Hz OSS frequency typically used in vitro to approximate the average resting heart rate of an individual3. The immunostaining comparisons showed disruptions in the endothelial monolayer and increased ICAM expression for 1 Hz case (Fig. 4a and b). Measuring the ICAM and β-catenin channel intensities revealed that while there was no significant difference in β-catenin expression, the 1 Hz case had a significantly higher expression of ICAM (Fig. 4c and d). Monitoring of the endothelial permeability revealed that the TEER significantly decreased only for the HAEC monolayers exposed to OSS of 1 Hz compared to HAEC monolayers exposed to OSS of 0.1 Hz (Fig. 4e). TEER measurements with iMAECs instead of HAECs also showed the TEER to drop significantly after passing a certain frequency threshold (Supplementary Fig. S4).
The design of the microfluidic transcellular monitor was based on the rationale that the endothelial cells cultured closer to the side walls of the microchannel with a rectangular cross section would exhibit different morphologies from experiencing different shear stress profiles; in our case specifically, the oscillatory fluid flow would have a more observable effect on endothelial cells cultured in the middle of the microchannel. Our results change the status quo of key design parameters to keep in mind when concerning microfluidic analyses of endothelial monolayers; there is now a cause for future double-layer microchannel platforms to more carefully take the microchannel configuration into consideration to minimize the influence of the microchannel wall on the experiment. With TEER measurements depending on the overlapping microchannel area, we took this design criteria into consideration by limiting the lower microchannel width to be half that of the upper microchannel25. The cultures of HUVECs under LSS and the cultures of HAECs under LSS and 1 Hz OSS were immunostained to validate our rationale and simulations with comparisons of mean cell area, β-catenin expression, and ICAM expression between the center (middle 50%) and edge regions (remaining 25% area on either side) of the upper microchannel.
Our validations of the insignificant differences between the net shears of +1 and +10 dyne/cm2 determined that the differences observed between our cases were due to the different flow frequency cases and not in the shear magnitudes. The monitoring of the endothelium during different OSS frequencies showed consistent results across both human and mouse endothelial cells, indicating that the endothelial sensitivity to OSS frequency was not species-limited. Our results also indicate that there is a frequency threshold that must be reached in order to stimulate endothelial inflammation with OSS, suggesting that there may be a range of frequencies over which endothelial cells will respond in a pro-inflammatory manner. While it is still unclear as to what the breadth of this endothelial pro-inflammatory frequency range includes, comparisons of our results with prior studies on the risks of resting heart rate and CVD suggest that higher resting heart rates, and thus potentially higher OSS frequencies, have higher risks of experiencing a CVD-related episode28, 29.
Our findings suggest that the inflammatory response of endothelial cells to OSS may be triggered by meeting a minimum frequency requirement. We demonstrated the design rationale behind our platform to take advantage of its capabilities to detect changes in both monolayer permeability and inflammatory marker expression in response to changes in OSS frequency. Future work to consider with this device would be to explore the extent of the frequency dependency by pairing the device with a more sophisticated fluid flow controller to impose high frequency flows, as well as to screen extensive libraries of nanomedicines and therapeutics targeting the endothelium to rapidly identify and catalogue endothelial responses30. The translation of these results across humans and mice may also be further pursued to help bridge the gap between human and animal models.
Materials and chemicals
The reagent (3-aminopropyl)triethoxysilane (APTES) was purchased from Sigma-Aldrich Co. LLC. (St. Louis, MO). Polydimethylsiloxane (PDMS) was purchased as Sylgard 184 from Dow Corning (Midland, MI). The photoresist SU-8 and its developer were purchased from MicroChem Corp (Westborough, MA). HAECs and HUVECs were purchased from ATCC (Manassas, VA) and ScienCell Research Laboratories (Carlsbad, CA) respectively. The iMAECs were generously donated from the lab of Dr. Hanjoong Jo.
Microfluidic transcellular monitor design and fabrication
The microfluidic transcellular monitor was first conceptualized using the CAD software SolidWorks from Dassault Systemes SolidWorks Corp. (Paris, France), after which we conducted computational flow studies using the Fluent solver (ANSYS, Inc. Concord, MA). The dimensions of the upper and lower microchannels were 200 µm × 100 µm and 100 µm × 50 µm respectively (width × height). All simulations were solved for a single fluid with the Newtonian properties of water and using a structured mesh for the device microchannel31, 32. The boundary condition at the device inlet was set to 20 µL/min and 2 µL/min for the average +10 and +1 dyne/cm2 conditions respectively to examine the distribution of the WSS in the cell-culture region of the upper microchannel. Fabrication of the device started with Ag electrodes patterned onto glass slides using metal evaporation deposition33. The thin PDMS sheet for the lower microchannel was made by spin coating PDMS to 250 µm in height onto an SU-8 patterned silicon wafer. The upper microchannel was constructed using standard soft lithography to a patterned wafer. An 8 µm pore polycarbonate membrane (Sterlitech Corp, Kent, WA) was then treated in a 5% APTES solution at 80 °C for device assembly prior to device housing34. The lower microchannel AgCl electrodes were produced using household bleach to soak the Ag electrodes for 1 hour at room temperature35. The fabricated device was housed in a polystyrene box for microfluidic cell culture using syringe pumps (Supplementary Fig. S1).
Microfluidic endothelial cell culture preparation
Prior to seeding cells into devices, HAECs, iMAECs, and HUVECs were cultured in EGM-2 (Lonza, Basel, Switzerland) and complete endothelial growth medium (DMEM with 10% FBS, 1% endothelial cell growth supplement (ECGS), and 1% penicillin and streptomycin) respectively. Cell media was replaced every 3 days, with cultures being split at confluence. The device, housing, and tubing were sterilized with 70% ethanol and washed with DI-water and PBS (1X, pH 7.4) prior to filling the microchannels with a fibronectin solution (50 µg/mL in PBS) and incubating the devices for 2 hs at 37 °C. After the fibronectin incubation period, the channels were rinsed with PBS prior to seeding cells into the devices at a concentration of approximately 1 × 107 cells/mL. Following a 1 h incubation at 37 °C, devices were connected to Harvard Apparatus (Holliston, MA) PhD Ultra syringe pumps and exposed to 20 µL/min (HAECs and HUVECs) or 14 µL/min (iMAECs) while incubating at 37 °C. To study the effects of OSS frequency, monolayers were cultured for 24 hours and 48 hours for HAECs and iMAECs respectively before applying the different shear frequencies (Supplementary Figs S3 and S4).
TEER measurements were taken every 12–24 hours at 37 °C using the EVOM2 volt-ohmmeter (World Precision Instruments, Sarasota, FL). A potential source of error is from noise in the TEER measurements, which was reduced by averaging multiple readings for each device at every time point, and by taking all measurements at the same temperature inside of a cell culture incubator, as TEER can also be affected by temperature fluctuations. Measurements were normalized to the mature monolayer value in each device relative to when there were no cells in the device (0 h).
Immunostaining of endothelial cells
Cell fixation was done using 4% paraformaldehyde (PFA) in PBS before permeabilizing in 0.1% triton. Samples were blocked with 1% bovine serum albumin (BSA) in PBS. Antibody incubation was with anti-β-catenin antibodies (ab32572, Abcam, Cambridge, UK) and Alexa Fluor 488 conjugated anti-ICAM-1 antibodies (322713, BioLegend, San Diego, CA) at 4 °C overnight followed by Alexa Fluor 647 conjugated secondary antibodies (ab150075, Abcam). Confocal microscopy imaging of the stained devices was done with a Zeiss LSM 700 microscope (Zeiss, Oberkochen, Germany).
Confocal images of each device were analyzed using the regions of interest (ROI) manager in ImageJ. For comparisons of the center and edge regions of the microchannel, the microchannel was parsed into 8 sections; the center 4 sections were used to define the center ROI, and the outer 4 sections were used to define the edge ROI. For the frequency dependency analyses, only the center ROI of the microchannels was compared. The individual channels for ICAM and β-catenin were used for ROI comparisons. HUVEC areas were calculated using ImageJ ROI manager, where cells were sorted into center and edge regions based on the area the cell occupied the most.
Statistical analyses were run in Prism 6 (GraphPad Software Inc, La Jolla, CA) and significance was defined as p < 0.05 (*). ANOVA tests were used to compare the TEER and immunostaining results of 0X, 0.1X, and 1X frequency cases, and t-tests were used for the +1/+10 dyne/cm2 LSS comparisons and the center/edge comparisons.
Libby, P., Ridker, P. M. & Maseri, A. Inflammation and atherosclerosis. Circulation 105, 1135–1143 (2002).
Packard, R. R. S. & Libby, P. Inflammation in Atherosclerosis: From Vascular Biology to Biomarker Discovery and Risk Prediction. Clinical Chemistry 54, 24–38, doi:10.1373/clinchem.2007.097360 (2008).
Chappell, D. C., Varner, S. E., Nerem, R. M., Medford, R. M. & Alexander, R. W. Oscillatory shear stress stimulates adhesion molecule expression in cultured human endothelium. Circ Res 82, 532–539 (1998).
Johnson, B. D., Mather, K. J. & Wallace, J. P. Mechanotransduction of shear in the endothelium: Basic studies and clinical implications. Vascular Medicine 16, 365–377, doi:10.1177/1358863X11422109 (2011).
Seebach, J. et al. Endothelial barrier function under laminar fluid shear stress. Lab Invest 80, 1819–1831 (2000).
Ku, D. N., Giddens, D. P., Zarins, C. K. & Glagov, S. Pulsatile flow and atherosclerosis in the human carotid bifurcation. Positive correlation between plaque location and low oscillating shear stress. Arteriosclerosis 5, 293–302 (1985).
Chatzizisis, Y. S. et al. Role of endothelial shear stress in the natural history of coronary atherosclerosis and vascular remodeling: molecular, cellular, and vascular behavior. Journal of the American College of Cardiology 49, 2379–2393, doi:10.1016/j.jacc.2007.02.059 (2007).
Cunningham, K. S. & Gotlieb, A. I. The role of shear stress in the pathogenesis of atherosclerosis. Lab Invest 85, 9–23, doi:10.1038/labinvest.3700215 (2005).
Hwang, J. et al. Oscillatory shear stress stimulates endothelial production of O2- from p47phox-dependent NAD(P)H oxidases, leading to monocyte adhesion. J Biol Chem 278, 47291–47298, doi:10.1074/jbc.M305150200 (2003).
Ni, C. W., Kumar, S., Ankeny, C. J. & Jo, H. Development of immortalized mouse aortic endothelial cell lines. Vasc Cell 6, 7, doi:10.1186/2045-824X-6-7 (2014).
Getz, G. S. & Reardon, C. A. Animal models of atherosclerosis. Arterioscler Thromb Vasc Biol 32, 1104–1115, doi:10.1161/ATVBAHA.111.237693 (2012).
Nam, D. et al. Partial carotid ligation is a model of acutely induced disturbed flow, leading to rapid endothelial dysfunction and atherosclerosis. American Journal of Physiology-Heart and Circulatory Physiology 297, doi:10.1152/ajpheart.00510.2009 (2009).
Sei, Y., Justus, K., LeDuc, P. & Kim, Y. Engineering living systems on chips: from cells to human on chips. Microfluid Nanofluid, doi:10.1007/s10404-014-1341-y (2014).
Chiu, J.-J. & Chien, S. Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives. Physiological Reviews 91, 327–387, doi:10.1152/physrev.00047.2009 (2011).
Sorescu, G. P. et al. Bone morphogenic protein 4 produced in endothelial cells by oscillatory shear stress stimulates an inflammatory response. J Biol Chem 278, 31128–31135, doi:10.1074/jbc.M300703200 (2003).
Velasco, V. et al. An orbital shear platform for real-time, in vitro endothelium characterization. Biotechnol Bioeng 113, 1336–1344, doi:10.1002/bit.25893 (2016).
Nam, D. et al. A model of disturbed flow-induced atherosclerosis in mouse carotid artery by partial ligation and a simple method of RNA isolation from carotid endothelium. J Vis Exp, doi:10.3791/1861 (2010).
Young, E. W. & Simmons, C. A. Macro- and microscale fluid flow systems for endothelial cell biology. Lab Chip 10, 143–160, doi:10.1039/b913390a (2010).
VanderLaan, P. A., Reardon, C. A. & Getz, G. S. Site specificity of atherosclerosis: site-selective responses to atherosclerotic modulators. Arterioscler Thromb Vasc Biol 24, 12–22, doi:10.1161/01.ATV.0000105054.43931.f0 (2004).
Himburg, H. A., Dowd, S. E. & Friedman, M. H. Frequency-dependent response of the vascular endothelium to pulsatile shear stress. Am J Physiol Heart Circ Physiol 293, H645–653, doi:10.1152/ajpheart.01087.2006 (2007).
Feaver, R. E., Gelfand, B. D. & Blackman, B. R. Human haemodynamic frequency harmonics regulate the inflammatory phenotype of vascular endothelial cells. Nat Commun 4, 1525, doi:10.1038/ncomms2530 (2013).
Bhatia, S. N. & Ingber, D. E. Microfluidic organs-on-chips. Nature Biotechnology 32, 760–772, doi:10.1038/nbt.2989 (2014).
Valencia, P. M., Farokhzad, O. C., Karnik, R. & Langer, R. Microfluidic Technologies for Accelerating the Clinical Translation of Nanoparticles. Nature Nanotechnology 7, 623–629, doi:10.1038/nnano.2012.168 (2012).
Kim, Y. et al. Probing nanoparticle translocation across the permeable endothelium in experimental atherosclerosis. Proceedings of the National Academy of Sciences of the United States of America 111, 1078–1083, doi:10.1073/pnas.1322725111 (2014).
Odijk, M. et al. Measuring direct current trans-epithelial electrical resistance in organ-on-a-chip microsystems. Lab on a Chip 15, 745–752, doi:10.1039/C4LC01219D (2014).
Hosoya, T. et al. Differential responses of the Nrf2-Keap1 system to laminar and oscillatory shear stresses in endothelial cells. J Biol Chem 280, 27244–27250, doi:10.1074/jbc.M502551200 (2005).
Ji, J. Y., Jing, H. Y. & Diamond, S. L. Hemodynamic regulation of inflammation at the endothelial-neutrophil interface. Annals of Biomedical Engineering 36, 586–595, doi:10.1007/s10439-008-9465-4 (2008).
Jouven, X. et al. Heart-rate profile during exercise as a predictor of sudden death. New Engl J Med 352, 1951–1958, doi:10.1056/NEJMoa043012 (2005).
Fox, K. et al. Resting heart rate in cardiovascular disease. J Am Coll Cardiol 50, 823–830, doi:10.1016/j.jacc.2007.04.079 (2007).
Chung, B. et al. Nanomedicines for Endothelial Disorders. Nano Today 10, 759–776, doi:10.1016/j.nantod.2015.11.009 (2015).
Kim, Y., Pekkan, K., Messner, W. C. & Leduc, P. R. Three-dimensional chemical profile manipulation using two-dimensional autonomous microfluidic control. J Am Chem Soc 132, 1339–1347, doi:10.1021/ja9079572 (2010).
Hengzi, W. et al. Optimizing layout of obstacles for enhanced mixing in microchannels. Smart Materials and Structures 11, 662–667 (2002).
Park, B. Y., Zaouk, R. & Madou, M. J. in Microfluidic Techniques: Reviews and Protocols (ed Shelley D. Minteer) 23–26 (Humana Press, 2006).
Aran, K., Sasso, L. A., Kamdar, N. & Zahn, J. D. Irreversible, direct bonding of nanoporous polymer membranes to PDMS or glass microdevices. Lab on a chip 10, 548–552, doi:10.1039/b924816a (2010).
Shinwari, M. W. et al. Microfabricated reference electrodes and their biosensing applications. Sensors (Basel) 10, 1679–1715, doi:10.3390/s100301679 (2010).
This work was supported by the American Heart Association Scientist Development Grant 15SDG25080314 (Y.K.), National Institute of Neurological Disorders and Stroke of the National Institutes of Health R21NS091682 (Y.K.), Cell and Tissue Engineering NIH Biotechnology Training Grant T32GM008433, ACTSI Emory/GA Tech Regenerative Engineering and Medicine (REM) Seed Grant (Y.K.), and by the Center for Pediatric Nanomedicine (CPN) of Children’s Healthcare of Atlanta Seed Grant. This work was performed in part at the Parker H. Petit Institute for Bioengineering and Bioscience at the Georgia Institute of Technology and at the Georgia Tech Institute for Electronics and Nanotechnology, a member of the National Nanotechnology Coordinated Infrastructure, which is supported by the National Science Foundation (Grant ECCS1542174). We also thank Dr. Hanjoong Jo for generously providing the iMAECs, Nicholas Stone for his assistance in device electrode coating, and Erisa Sula for her assistance in device fabrication.
The authors declare that they have no competing interests.
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
About this article
Cite this article
Sei, Y.J., Ahn, S.I., Virtue, T. et al. Detection of frequency-dependent endothelial response to oscillatory shear stress using a microfluidic transcellular monitor. Sci Rep 7, 10019 (2017). https://doi.org/10.1038/s41598-017-10636-z
This article is cited by
Biomedical Engineering Letters (2023)
BioChip Journal (2022)
Microvascularized tumor organoids-on-chips: advancing preclinical drug screening with pathophysiological relevance
Nano Convergence (2021)
Microsystems & Nanoengineering (2021)
Microfluidic models of the human circulatory system: versatile platforms for exploring mechanobiology and disease modeling
Biophysical Reviews (2021)